申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US04563455A1
公开(公告)日:1986-01-07
New fused imidazole compounds of the formula: ##STR1## wherein A is lower alkylene, R.sup.1 is hydrogen, lower alkyl, lower alkoxy or halogen, R.sup.2 is hydrogen, lower alkyl, cyclo(lower)alkyl, pyridyl, ar(lower)alkyl which may be substituted with halogen, or aryl which may be substituted with lower alkyl, lower alkoxy, hydroxy or halogen, R.sup.3 is N-containing unsaturated heterocyclic group which may be substituted with lower alkyl or amino, and Y is .dbd.C-- or .dbd.N--, and pharmaceutically acceptable salts thereof, and processes for preparation thereof and pharmaceutical composition comprising the same. These derivatives and salts thereof are useful as antiulcer agents.
新的融合咪唑化合物的化学式如下:##STR1## 其中A为较低的烷基,R.sup.1为氢、较低的烷基、较低的烷氧基或卤素,R.sup.2为氢、较低的烷基、环(较低)烷基、吡啶基、含氮的不饱和杂环基,可以用卤素取代的芳基或被较低的烷基、较低的烷氧基、羟基或卤素取代的芳基,R.sup.3为可能用较低的烷基或氨基取代的含氮不饱和杂环基,Y为.dbd.C--或.dbd.N--,以及其药学上可接受的盐,以及其制备方法和包含它们的药物组合物。这些衍生物及其盐可用作抗溃疡药物。